Is cytomegalovirus infection causative for coronary heart disease?

References

[1]  Seale, H. et al. (2006) National serosurvey of cytomegalovirus in Australia. Clin. Vaccine Immunol. 13, 1181–1184.
| National serosurvey of cytomegalovirus in Australia.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD28Xht1Gksb7N&md5=21287eb1445b5528507aa064e1159cd8CAS | 16957061PubMed |

[2]  Sinzger, C. and Jahn, G. (1996) Human cytomegalovirus cell tropism and pathogenesis. Intervirology 39, 302–319.
| 1:STN:280:DyaK2s3ns1arug%3D%3D&md5=82beaaf1976eca307670019032492732CAS | 9130041PubMed |

[3]  Melnick, J.L. et al. (1983) Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet 322, 644–647.
| Cytomegalovirus antigen within human arterial smooth muscle cells.Crossref | GoogleScholarGoogle Scholar |

[4]  Petrie, B.L. et al. (1987) Nucleic acid sequence of cytomegalovirus in cells cultured from human arterial tissue. J. Infect. Dis. 155, 158–159.
| Nucleic acid sequence of cytomegalovirus in cells cultured from human arterial tissue.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaL2s%2FosV2hsA%3D%3D&md5=561fed9d4f654208415aeb37154d9cc6CAS | 3025305PubMed |

[5]  Hendricks, M.G. et al. (1990) High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am. J. Pathol. 136, 23–28.

[6]  Yamashiroya, H.M. et al. (1988) Herpesviridae in the coronary arteries and aorta of young trauma victims. Am. J. Pathol. 130, 71–79.
| 1:STN:280:DyaL1c7gtl2ktw%3D%3D&md5=6dc2b4241a5872cfdc4d592d5b0e0cc5CAS | 2827495PubMed |

[7]  Melnick, J.L. et al. (1994) Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J. Med. Virol. 42, 170–174.
| Cytomegalovirus DNA in arterial walls of patients with atherosclerosis.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DyaK2cXmtVait78%3D&md5=9570465da44b6c72b95f2d9a757739e7CAS | 8158112PubMed |

[8]  Chen, R. et al. (2003) The relationship between human cytomegalovirus infection and atherosclerosis development. Mol. Cell. Biochem. 249, 91–96.
| The relationship between human cytomegalovirus infection and atherosclerosis development.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD3sXlsVKls70%3D&md5=b7e937f5eb83d64f8f11c00d6567beddCAS | 12956403PubMed |

[9]  Liu, R. et al. (2006) Presence and severity of Chlamydia pneumoniae and Cytomegalovirus infection in coronary plaques are associated with acute coronary syndromes. Int. Heart J. 47, 511–519.
| Presence and severity of Chlamydia pneumoniae and Cytomegalovirus infection in coronary plaques are associated with acute coronary syndromes.Crossref | GoogleScholarGoogle Scholar | 16960406PubMed |

[10]  Daus, H. et al. (1998) Lack of evidence for a pathogenic role of Chlamydia pneumoniae and cytomegalovirus infection in coronary atheroma formation. Cardiology 90, 83–88.
| Lack of evidence for a pathogenic role of Chlamydia pneumoniae and cytomegalovirus infection in coronary atheroma formation.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK1cvltlemtg%3D%3D&md5=459eb5bfe77bf006ef8492763fd236e0CAS | 9778543PubMed |

[11]  Saetta, A. et al. (2000) Atherosclerosis of the carotid artery; absence of evidence for CMV involvement in atheroma formation. Cardiovasc. Pathol. 9, 181–183.
| Atherosclerosis of the carotid artery; absence of evidence for CMV involvement in atheroma formation.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3cvktlOgtQ%3D%3D&md5=d7ba4b796c0a91d277fcc7eae3a8d551CAS | 10989318PubMed |

[12]  Kol, A. et al. (1995) Cytomegalovirus replication is not a cause of instability in unstable angina. Circulation 91, 1910–1913.
| Cytomegalovirus replication is not a cause of instability in unstable angina.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK2M3gt1yjug%3D%3D&md5=7a6194d3eaf39220b0bccbdc176e140bCAS | 7895346PubMed |

[13]  Danesh, J. et al. (1997) Chronic infection and coronary heart disease: is there a link? Lancet 350, 430–436.
| Chronic infection and coronary heart disease: is there a link?Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK2svgs1ajtA%3D%3D&md5=8029277c04d5c3316344140b8e726c4aCAS | 9259669PubMed |

[14]  Ji, Y.-N. et al. (2012) Cytomegalovirus infection and coronary heart disease risk: a meta-analysis. Mol. Biol. Rep. 39, 6537–6546.
| Cytomegalovirus infection and coronary heart disease risk: a meta-analysis.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC38XlvFarsbc%3D&md5=92e2ecd1993cb458c9eb355162072975CAS | 22311014PubMed |

[15]  Nieto, F.J. et al. (1996) Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation 94, 922–927.
| Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK28zot1WlsA%3D%3D&md5=48e79e3ba4c4c47adb81206a2f6647f1CAS | 8790026PubMed |

[16]  Blum, A. et al. (1998) High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis. Am. J. Cardiol. 81, 866–868.
| High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK1c3hsFSmuw%3D%3D&md5=14a3c20b9cef418299fbf3fe2fa22d71CAS | 9555776PubMed |

[17]  Gattone, M. et al. (2001) Chlamydia pneumoniae and cytomegalovirus seropositivity, inflammatory markers, and the risk of myocardial infarction at a young age. Am. Heart J. 142, 633–640.
|  Chlamydia pneumoniae and cytomegalovirus seropositivity, inflammatory markers, and the risk of myocardial infarction at a young age.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3Mrjtlyguw%3D%3D&md5=72e89f6ff52f28ee8291e68e0de3979fCAS | 11579353PubMed |

[18]  Zhou, Y.F. et al. (1996) Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells. J. Clin. Invest. 98, 2129–2138.
| Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DyaK28XmvVequ7o%3D&md5=ad1420d3063970bb497e318ecef9f842CAS | 8903333PubMed |

[19]  Reinhardt, B. et al. (2005) HCMV infection of human vascular smooth muscle cells leads to enhanced expression of functionally intact PDGF beta-receptor. Cardiovasc. Res. 67, 151–160.
| HCMV infection of human vascular smooth muscle cells leads to enhanced expression of functionally intact PDGF beta-receptor.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD2MXltFSrur4%3D&md5=408410fe5302eb283681af14e745ec78CAS | 15949479PubMed |

[20]  Tanaka, K. et al. (1999) Effects of human cytomegalovirus immediate-early proteins on p53-mediated apoptosis in coronary artery smooth muscle cells. Circulation 99, 1656–1659.
| Effects of human cytomegalovirus immediate-early proteins on p53-mediated apoptosis in coronary artery smooth muscle cells.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DyaK1MXisFalsbw%3D&md5=2ce64d83aaa4347df2169b14fd4ce06fCAS | 10190872PubMed |

[21]  Knight, D.A. et al. (1999) Cytomegalovirus-mediated modulation of adhesion molecule expression by human arterial and microvascular endothelial cells. Transplantation 68, 1814–1818.
| Cytomegalovirus-mediated modulation of adhesion molecule expression by human arterial and microvascular endothelial cells.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD3cXlsVKnug%3D%3D&md5=dd211d0ee281cb0abd3e1dfb5aca03a7CAS | 10609963PubMed |

[22]  Van Dam-Mieras, M.C.E. et al. (1987) Induction of endothelial cell procoagulant activity by cytomegalovirus infection. Thromb. Res. 47, 69–75.
| Induction of endothelial cell procoagulant activity by cytomegalovirus infection.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaL1c%2FhvVKqsw%3D%3D&md5=538a783b4ae18c81d91dfaca1d05a318CAS |

[23]  Prösch, S. et al. (2001) CCAAT/enhancer-binding proteins α and β negatively influence the capacity of tumor necrosis factor α to up-regulate the human cytomegalovirus IE1/2 enhancer/promoter by nuclear factor κB during monocyte differentiation. J. Biol. Chem. 276, 40 712–40 720.
| CCAAT/enhancer-binding proteins α and β negatively influence the capacity of tumor necrosis factor α to up-regulate the human cytomegalovirus IE1/2 enhancer/promoter by nuclear factor κB during monocyte differentiation.Crossref | GoogleScholarGoogle Scholar |

[24]  Vliegen, I. et al. (2004) Cytomegalovirus infection aggravates atherogenesis in apoE knockout mice by both local and systemic immune activation. Microbes Infect. 6, 17–24.
| Cytomegalovirus infection aggravates atherogenesis in apoE knockout mice by both local and systemic immune activation.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD2cXltFahsQ%3D%3D&md5=4c067b0ef369e6f4cf651f2b3ed0b157CAS | 14738889PubMed |

[25]  Burnett, M.S. et al. (2001) Atherosclerosis in apoE knockout mice infected with multiple pathogens. J. Infect. Dis. 183, 226–231.
| Atherosclerosis in apoE knockout mice infected with multiple pathogens.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3M7is1WltA%3D%3D&md5=b4a7937f747cfe023a17ac41cd360a97CAS | 11120928PubMed |

[26]  Hsich, E. et al. (2001) Cytomegalovirus infection increases development of atherosclerosis in apolipoprotein-E knockout mice. Atherosclerosis 156, 23–28.
| Cytomegalovirus infection increases development of atherosclerosis in apolipoprotein-E knockout mice.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD3MXjtlCitbw%3D&md5=d95c6d4be1ae01c10cae1c75e8f0bdd1CAS | 11368993PubMed |

[27]  Cheng, J. et al. (2009) Cytomegalovirus infection causes an increase of arterial blood pressure. PLoS Pathog. 5, e1000427.
| Cytomegalovirus infection causes an increase of arterial blood pressure.Crossref | GoogleScholarGoogle Scholar | 19436702PubMed |

[28]  Vliegen, I. et al. (2005) Mouse cytomegalovirus antigenic immune stimulation is sufficient to aggravate atherosclerosis in hypercholesterolemic mice. Atherosclerosis 181, 39–44.
| Mouse cytomegalovirus antigenic immune stimulation is sufficient to aggravate atherosclerosis in hypercholesterolemic mice.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD2MXltFWjsbk%3D&md5=371db12a81d02c20e2baac237e9cfc6fCAS | 15939052PubMed |